ISPO

Risk Assessment I

Telomerase and cancer: diagnostic, prognostic and therapeutic implications

JW Shay PhD

Molecular genetics and cancer risk prediction: cancer risks associated with p53 germline mutations

LC Strong, LSC Cheng

Carcinogenic susceptibility

S Parodi MD PhD, M Taningher

Retinoids and lung cancer prevention

S Langenfeld MD, F Lonardo MD, D Klimstra MD, V Rusch MD, E Dmitrovsky MD

Biomarkers of carcinogen exposure

RM Santella